Do patients with schizophrenia ever show periods of recovery? A 15-year multi-follow-up study

Schizophrenia Bulletin

Volumn 31, Issue 3, 2005, Pages 723-734

  Harrow, Martin ^a   Grossman, Linda S ^a   Jobe, Thomas H ^a   Herbener, Ellen S ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RESEARCH; MENTAL DISEASE; OUTCOMES RESEARCH; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCHIZOPHRENIA; SCHIZOPHRENIFORM DISORDER; SOCIAL ASPECT;

ADULT; CASE-CONTROL STUDIES; CHRONIC DISEASE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; PROGNOSIS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SEVERITY OF ILLNESS INDEX; SOCIAL ISOLATION; TREATMENT OUTCOME;

EID: 24344453867     PISSN: 05867614     EISSN: None     Source Type: Journal    
DOI: 10.1093/schbul/sbi026     Document Type: Article

References (79)

1. Bleuler M. The Schizophrenic Disorders: Long-Term Patient and Family Studies. New Haven: Yale University Press; 1978.
2. Vaillant G. A 10-year followup of remitting schizophrenics. Schizophrenia Bull 1978;4:78-85.
3. Tsuang M, Woolson R, Fleming J. Long-term outcome of major psychoses: I schizophrenia and affective disorders compared with psychiatrically symptom-free surgical conditions. Arch Gen Psychiat 1979;36:1295-1301.
4. Angst J. European long-term studies of schizophrenia. Schizophrenia Bull 1988;14:501-513.
5. Carpenter W, Kirkpatrick B. The heterogeneity of the long-term course of schizophrenia. Schizophrenia Bull 1988;14:645-652.
6. McGlashan T. A selective review of recent North American long-term follow-up studies of schizophrenia. Schizophrenia Bull 1988;14:515-540.
7. Carone J, Harrow M, Westermeyer J. Posthospital course and outcome in schizophrenia. Arch Gen Psychiat 1991;48:247-253.
8. Breier A, Schreiber J, Dyer J, Pickar D. National Institute of Mental Health longitudinal study of chronic schizophrenia: prognosis and predictors of outcome. Arch Gen Psychiat 1991;48:236-246.
9. Carpenter W, Strauss J. The prediction of outcome in schizophrenia IV: eleven-year follow-up of the Washington IPSS cohort. J Nerv Ment Dis 1991;179:517-525.
10. Harrison G, Hopper K, Craig T. Recovery from psychotic illness: a 15- and 25-year international follow-up study. Brit J Psychiat 2001;178:506-517.
11. Johnstone E. What is crucial for the long-term outcome of schizophrenia? In: Häfner H, Gattaz W, eds. Search for the Cause of Schizophrenia. Berlin: Springer-Verlag; 1990;67-76.
12. Winokur G, Tsuang M. The Natural History of Mania, Depression, and Schizophrenia. Washington, DC: American Psychiatric Press; 1996.
13. Liberman R, Kopelowicz A. Recovery from schizophrenia: a challenge for the 21st century. Int Rev Psychiatr 2002;14:245-255.
14. Strauss J. Translating new research into strategies of care. Yale Psychiatric Quarterly 1989;January:2-3.
15. Robinson D, Woerner M, McMeniman M, Mendelowitz A, Bilder R. Symptomatic and functional recovery from a first episode of schizophrenia or schizoaffective disorder. Am J Psychiat 2004;161:473-479.
16. Bleuler E. Dementia Praecox or the Group of Schizophrenias. New York: International Universities Press; 1950[1911].
17. Kraepelin E. Dementia Praecox and Paraphrenia. New York: Robert E. Krieger Publishing Co. Inc; 1971[1919].
18. May P, Tuma A, Dixon W, Yale C, Thiele D, Kraude W. Schizophrenia: a follow-up study of the results of five forms of treatment. Arch Gen Psychiat 1981;38:776-784.
19. Hogarty G, Goldberg S, Schooler N, Urich R. Drug and sociotherapy in the aftercare of schizophrenic patients: II. two-year relapse rates. Arch Gen Psychiat 1974;31:603-608.
20. Harrow M, Sands J, Silverstein M, Goldberg J. Course and outcome for schizophrenia vs other psychotic patients: a longitudinal study. Schizophrenia Bull 1997;23:287-303.
21. Harrow M, Grossman L, Herbener E, Davis E. Ten-year outcome: patients with schizoaffective disorders, schizophrenia, affective disorders, and mood-incongruent psychotic symptoms. Brit J Psychiat 2000;177:421-426.
22. Liberman R, Kopelowicz A, Ventura J, Gutkind D. Operational criteria and factors related to recovery from schizophrenia. Int Rev Psychiatr 2002;14:256-272.
23. Liberman R. Future directions for research studies and clinical work on recovery from schizophrenia: questions with some answers. Int Rev Psychiatr 2002;14:337-342.
24. Russinova Z, Wewiorski N, Lyass A, Rogers E, Massaro J. Correlates of vocational recovery for persons with schizophrenia. Int Rev Psychiatr 2002;14:303-311.
25. Spaniol L, Wewiorski N, Gagne C, Anthony W. The process of recovery from schizophrenia. Int Rev Psychiatr 2002;14:327-336.
26. Goldberg J, Harrow M. Risk for bipolar illness in patients initially hospitalized for unipolar major depression. Am J Psychiat 2001;158:1265-1270.
27. Herbener E, Harrow M. Are negative symptoms associated with functioning deficits in both schizophrenic and non-schizophrenic patients? a ten-year longitudinal analysis. Schizophrenia Bull 2004;30:813-825.
28. Harrow M, Grossman L, Jobe T, Goldberg J, Faull R. Do schizophrenics show periods of complete recovery: a 20 year followup. Scientific Proceedings of the 157th Annual Meeting of the American Psychiatric Association, 76. Washington, DC: American Psychiatric Association; 2004.
29. Marengo J, Harrow M, Sands J, Galloway C. European vs USA data on the course of schizophrenia. Am J Psychiat 1991;148:606-612.
30. Harrow M, Goldberg J, Grossman L, Meltzer H. Outcome in manic disorders: a naturalistic followup study. Arch Gen Psychiat 1990;47:665-671.
31. Endicott J, Spitzer R. A diagnostic interview. Arch Gen Psychiat 1978;35:837-844.
32. Grinker R, Harrow M. Clinical Research in Schizophrenia: A Multidimensional Approach. Springfield, IL: Charles C. Thomas; 1987.
33. Hollingshead A, Redlich F. Social Class and Mental Illness. New York: John Wiley and Sons; 1958.
34. Levenstein DSW, Klein DF, Pollack M. Follow-up study of formerly hospitalized voluntary psychiatric patients: the first two years. Am J Psychiat 1966;122:1102-1109.
35. Goldberg J, Harrow M, Grossman L. Course and outcome in bipolar affective disorders: a longitudinal followup study. Am J Psychiat 1995;152:379-384.
36. Endicott J, Spitzer R, Fleiss J, Cohen J. The Global Assessment Scale: a procedure for measuring overall severity of psychiatric disturbance. Arch Gen Psychiat 1976;33:766-771.
37. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association; 2000.
38. Strauss J, Carpenter W. The prediction of outcome in schizophrenia: I characteristics of outcome. Arch Gen Psychiat 1972;17:739-746.
39. Andreasen N, Carpenter W, Kane J, Lasser R, Marder S, Weinberger M. Remission in schizophrenia: proposed criteria and rationale for consensus. Am J Psychiat 2005;162:441-449.
40. Whitehorn D, Brown J, Richard J, Rui Q, Kopala L. Multiple dimensions of recovery in early psychosis. Int Rev Psychiatr 2002;14:273-283.
41. Corrigan PW, Giffort D, Rashid F, Leary M, Okeke I. Recovery as a psychological construct. Community Ment Hlt J 1999;35:231-239.
42. Frank E, Prien RF, Jarrett RB, et al. Conceptualization and rationale for consensus definitions of terms in major depressive disorder: remission, recovery, relapse, and recurrence. Arch Gen Psychiat 1991;48:851-855.
43. Noordsy D, Torrey W, Mueser K, Mead S, O'Keefe C, Fox L. Recovery from severe mental illness: an intrapersonal and functional outcome definition. Int Rev Psychiatr 2002;14:318-326.
44. Prien RF, Carpenter LL, Kupfer DJ. The definition and operational criteria for treatment outcome of major depressive disorder: a review of the current research literature. Arch Gen Psychiat 1991;48:796-800.
45. Marengo J, Harrow M, Westermeyer J. Early longitudinal course of acute-chronic and paranoid-undifferentiated schizophrenia subtypes and schizophreniform disorder. J Abnorm Psychol 1991;100:600-603.
46. Astrup C, Fossum A, Holmboe R. Prognosis in Functional Psychoses. Springfield, IL: Charles C. Thomas; 1962.
47. Strauss J, Carpenter WJ. Prediction of outcome in schizophrenia, III: five year outcome and its predictors. Arch Gen Psychiat 1977;34:159-163.
48. Fenton W, McGlashan T. Sustained remission in drug-free schizophrenic patients. Am J Psychiat 1987;144:1306-1309.
49. Harrow M, Jobe T, Grossman L, Martin E, Faull R. Do all patients with schizophrenia need antipsychotic medications continuously? a 20-year multi-follow-up study. Schizophrenia Bull 2005;31:486.
50. Harrow M, Yonan C, Sands J, Marengo J. Depression in schizophrenia: are neuroleptics akinesia or anhedonia involved? Schizophrenia Bull 1994;20:327-338.
51. Seeman P, Tallerico T. Rapid release of antipsychotic drugs from dopamine D2 receptors: an explanation for low receptor occupancy and early clinical relapse upon withdrawal of clozapine or quetiapine. Am J Psychiat 1999;156:876-884.
52. Margolese H, Chouinard G, Beauclair L, Belanger M-C. Therapeutic tolerance and rebound psychosis during quetiapine maintenance monotherapy in patients with schizophrenia and schizoaffective disorder. J Clin Psychopharm 2002;22:347-352.
53. McIntyre R, McCann S, Kennedy S. Antipsychotic metabolic effects: weight gain, diabetes mellitus, and lipid abnormalities. Can J Psychiat 2001;46:273-281.
54. American Diabetes Association. Consensus development conference on antipsychotic drugs and obesity (consensus statement). Diabetes Care 2004;27:596-601.
55. Jobe T, Harrow M. Long-term outcome of patients with schizophrenia: A review. Can J Psychiat; in press.
56. Harding C, Brooks G, Ashikiga T, Strauss J, Breier A. The Vermont longitudinal study of persons with severe mental illness: II. long-term outcome of subjects who retrospectively met DSM-III criteria for schizophrenia. Am J Psychiat 1987;144:727-735.
57. McGlashan T. The Chestnut Lodge Followup Study, II: long-term outcome of schizophrenia and the affective disorders. Arch Gen Psychiat 1984;41:586-601.
58. Harrow M, Grossman L, Sands J, Jobe T, Flaherty J. Does gender influence outcome in modern day schizophrenia? Schizophr Res 1995;15:191.
59. Harrow M., Jobe T., Grossman, L., Goldberg J., Faull R. Premorbid developmental achievements and later recovery in schizophrenia. Paper presented at the 158th Annual Meeting of the American Psychiatric Association, Atlanta; May 21-26, 2005.
60. Westermeyer J, Harrow M. Prognosis and outcome using broad DSM-II and narrow DSM-III concepts of schizophrenia. Schizophrenia Bull 1984;10:624-637.
61. Harrow M, Westermeyer JF. Process-reactive dimension and outcome for narrow concepts of schizophrenia. Schizophrenia Bull 1987;13:361-368.
62. Kopelowicz A. Introduction to recovery from schizophrenia: a challenge for the 21st century. Paper presented at the 156th Annual Meeting of the American Psychiatric Association, San Francisco; May 17-22, 2003.
63. Tooth B, Kalyanasundaram V, Glover H, Momenzadah S. Factors consumers identify as important to recovery from schizophrenia. Australas Psychiat 2003;11:70-77.
64. Harding C, Zahniser J. Empirical correction of seven myths about schizophrenia with implications for treatment. Acta Psychiat Scand 1994;90(suppl 384):140-146.
65. Harrow M, McDonald A, Sands J, Silverstein M. Vulnerability to delusions over time in schizophrenia, schizoaffective and bipolar and unipolar affective disorders: a multi-followup assessment. Schizophrenia Bull 1995;21:95-109.
66. Harding C, Zubin J, Strauss J. Chronicity in schizophrenia: fact, partial fact, or artifact? Hosp Community Psych 1987;38:477-486.
67. Harrow M, Herbener E, Shanklin A, Jobe J, Rattenbury F, Kaplan K. Followup of psychotic outpatients: dimensions of delusions and work functioning in schizophrenia. Schizophrenia Bull 2004;30:147-161.
68. Racenstein J, Harrow M, Reed R, Martin E, Herbener E, Penn D. The relationship between positive symptoms and instrumental functioning in schizophrenia: a 10-year followup study. Schizophr Res 2002;56:95-103.
69. Racenstein J, Penn D, Harrow M, Schlessor R. Thought disorder and psychological functioning in schizophrenia: concurrent and predictive relationships. J Nerv Ment Dis 1999;187:281-289.
70. Marengo J, Harrow M. The longitudinal courses of thought disorder in schizophrenia and schizoaffective disorder. Schizophrenia Bull 1997;23:273-285.
71. Herbener E, Harrow M. Longitudinal assessment of negative symptoms in schizophrenia/schizoaffective patients, other psychotic patients and depressed patients. Schizophrenia Bull 2001;27:527-537.
72. Pogue-Guile F, Harrow M. Negative symptoms in schizophrenia: their longitudinal course and prognostic importance. Schizophrenia Bull 1985;11:427-439.
73. Davidson L, McGlashan T. The varied outcomes of schizophrenia. Can J Psychiat 1997;42:34-43.
74. Carpenter WJ, Heinrichs D, Wagman A. Deficit and nondeficit forms of schizophrenia: the concept. Am J Psychiat 1988;145:578-583.
75. Kirkpatrick B, Buchanan R, Ross D, Carpenter WJ. A separate disease within the syndrome of schizophrenia. Arch Gen Psychiat 2001;58:165-171.
76. Marengo J, Harrow M, Westermeyer J. The early longitudinal course of symptoms and adjustment in RDC and DSM-III schizophrenia subtypes and DSM-III schizophreniform disorder. J Abnorm Psychol 1991;100:600-603.
77. Coryell W, Tsuang M. DSM-III schizophreniform disorder: comparisons with schizophrenia and affective disorder. Arch Gen Psychiat 1982;39:66-69.
78. Coryell W, Tsuang M. Outcome after 40 years in DSM-III schizophreniform disorder. Arch Gen Psychiat 1986;43:324-328.
79. Sands J, Harrow M. Psychotic unipolar depression at followup: factors related to psychosis in the affective disorders. Am J Psychiat 1994;151:995-1000.